Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C symptoms and diagnosis news

Show

From To
Fatty liver may contribute to higher risk of death for HIV/HCV co-infected people

About a quarter of people in a New York City cohort who had HIV and hepatitis C virus (HCV) died over a ten-year period – a "strikingly

Published
26 August 2015
By
Liz Highleyman
Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection

The development of effective new interferon-free treatment makes it possible to cure more than 90% of people with chronic hepatitis C, including most people with HIV and hepatitis

Published
20 July 2015
By
Liz Highleyman
Public health surveillance system may underestimate cases of acute hepatitis C infection

A new study suggests massive under reporting may occur within the system set up by the US Centers for Disease Control and Prevention to estimate the incidence of acute hepatitis C virus infection. A research team found that less than 1 percent of a group of acute HCV patients in Massachusetts had been reported to the CDC, largely because required data was either not available or did not meet CDC definitions for acute HCV infection.

Published
02 July 2015
From
Eurekalert Inf Dis
Liver transplants in HIV/HCV co-infection: study underlines importance of hepatitis C treatment

People with HIV and hepatitis C co-infection were significantly more likely to experience organ rejection than people with hepatitis C alone or HIV alone after undergoing a

Published
26 June 2015
By
Keith Alcorn
Hepatitis C Virus Infection and Alcohol: Challenges and Opportunities

This report, prepared by Professor David Goldberg and supported by Bristol Myers-Squibb, looks at the linkages between excessive alcohol consumption and hepatitis C, and explores how excessive alcohol consumption can act as a barrier to people with hepatitis C being considered for, receiving and the benefit of treatment for hepatitis C.

Published
24 June 2015
From
HCV Action
Hepatitis C: 25 Years Old, and Fading

At this year's Digestive Disease Week, investigators discussed issues related to screening efforts, the natural history of HCV infection, the safety and efficacy of the next wave of antiviral agents, access to care, and affordability of treatment.

Published
17 June 2015
From
Medscape
Hepatitis cases responsible for 93% of prison disease reports

The increase in reports reflects significant improvements in testing for hepatitis and other blood borne viruses (BBV) in prisons, which in a major change is moving from an ‘opt-in’ to an ‘opt-out’ policy to help reduce transmissions.

Published
16 June 2015
From
Public Health England press release
UNITAID brings innovation to the global response to HIV/AIDS, TB and Malaria

At a meeting in Rio de Janeiro, the Executive Board announced it would as a first step focus investments in three areas: improving antiretroviral therapy for adults in low and middle-income countries; enabling the expanded use, or "scale-up", of first pre-exposure prophylaxis (PrEP) as a means of preventing HIV transmission; and the development of better tools to diagnose hepatitis C virus (HCV), in particular for people who are co-infected with HIV/HCV.

Published
08 June 2015
From
UNITAID
Hepatitis B and C - An Action Plan for Saving Lives in Europe

Last year, leading experts, institutions, patient organisations and pharmaceutical industry representatives met and agreed that the major recommendations produced between 2011 and 2014 should be compiled into one comprehensive document, to make it easier for policy makers, decision makers, civil society organisations and healthcare institutions to tackle viral hepatitis effectively.

Published
20 May 2015
From
European Liver Patients Association
Statin use associated with lower risk of liver decompensation and death in hepatitis C patients with cirrhosis

People with hepatitis and liver cirrhosis were significantly less likely to progress to decompensated disease and less likely to die if they used statins to control blood

Published
19 May 2015
By
Liz Highleyman
← First12345...13Next →

Filter by country